Mercachem logo voor websites


Update COVID-19:

The COVID-19 situation is currently impacting most of the globe, including Asia, Europe and North America. At all MercachemSyncom sites, we follow the recommendations of the local competent authorities as they are released. We have established a series of contingency measures aimed at reducing risks for our employees, their families and the MercachemSyncom Operations. These measures are proactively being reassessed at regular intervals and adapted as deemed appropriate.

The MercachemSyncom team is united and determined to face the situation with the energy, strength and passion that constitute one of our hallmarks.


LinkedIn

Nijmegen, Groningen, Weert (The Netherlands), Prague (Czech Republic) –March 12, 2020

Following the successful acquisition of the cGMP drug substance production site in Weert earlier this year, MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, is pleased to announce several changes in its organization to position the company for the next phase of growth and development. Please read the press release below for details regarding those changes.

 

Full press release   

Contact us